Author

Courtney A. Barkley

University of Alabama at BirminghamORCID 0000-0002-6207-9995Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Aarón Silva-SáncheziD· 1 shared Anna F HowardiD· 1 shared Christina OchsenbaueriD· 1 shared Christopher M. WeissiD· 1 shared Davide BottaiD· 1 shared Davies KalangeiD· 1 shared Diana M. Soto-MartíneziD· 1 shared Fen ZhouiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aarón Silva-SánchezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Performance of Rilpivirine-Based Hydrophobic Tags and PROTACs Directed Against HIV-1 Reverse Transcriptase

Ferdinand K. Amanor, Garrett D. Clements, Rabia Khurshid, Anna F Howard, Diana M. Soto-Martínez, Courtney A. Barkley, Zhengrong W. Yang, Kabita Gyawali, John C. Kappes, Robert C. Reynolds, Stephan C. Schürer, Timothy S. Snowden, Christina Ochsenbauer

The paper evaluates rilpivirine-based hydrophobic tags and PROTACs for HIV-1 RT degradation, finding that PEG4-Ad shows low nanomolar potency but limited efficacy against resistance mutations.

bioRxiv · Sep 25, 2026 · PreprintMicrobiology

Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infection

Davide Botta, Michael D. Schultz, Aarón Silva-Sánchez, Davies Kalange, Jobaida Akther, Fen Zhou, Jennifer L. Tipper, Guang Yang, Levi Schaefers, Courtney A. Barkley, Shihong Qiu, Jeremy B. Foote, Mariana F. Tioni, Christopher M. Weiss, Shannon I. Phan, , Frances E. Lund

This study evaluates two RSV-vectored SARS-CoV-2 vaccines, showing they induce systemic and mucosal immunity and protect against viral challenge and natural infection.

Vaccines · Apr 29, 2026Peer-reviewedImmunology